NDC 72511-143 – Repatha

Evolocumab 140 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC72511-143

Product details

Brand name
Repatha
Generic name
Evolocumab
Labeler
Amgen USA Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA125522
Marketed since
July 13, 2026
Listing expires
December 31, 2027
Pharmacologic class
PCSK9 Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Repatha →

Package NDC codes (3)

Package NDCDescriptionSince
72511-143-011 SYRINGE in 1 CARTON (72511-143-01) / 1 mL in 1 SYRINGEJul 13, 2026
72511-143-021 SYRINGE in 1 CARTON (72511-143-02) / 1 mL in 1 SYRINGEJul 13, 2026
72511-143-96 sample1 SYRINGE in 1 CARTON (72511-143-96) / 1 mL in 1 SYRINGEJul 13, 2026

Other Repatha products